CAH Cardinal Health, Inc.
$246.45▼ -2.02%
Healthcare
Other
After hours
$246.45▲ +0.00%
Oct 27, 5:23 PM ET
Volume 1.58M
Avg Volume (10D) 1.88M
Key Metrics & Fundamentals
Market Cap
$57.07B
P/E Ratio
34.1
Div Yield
0.82%
52W Range
161.64 - 259.21
% vs 50 MA
4.07%
% vs 200 MA
11.24%
RSI-14
54.8
MACD Histogram
+0.3400
Beta (1Y vs SPY)
-0.12
Free Cash Flow
$1.43B
Gross Rev
$63.67B
Gross Profit
$2.56B
EBITDA
$1.08B
COGS
$61.11B
Operating Exp
$1.75B
Operating Income
$814.00M
EBIT
$814.00M
Pretax Income
$554.00M
Net Income
$398.00M
EPS (Diluted)
1.70
Price & Volume History
Loading chart…
Recent News

Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Zacks · Oct 27, 2026 5:00 PM ET

Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results
Investor's Business Daily · Oct 27, 2026 1:47 PM ET

Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?
Motley Fool · Oct 27, 2026 11:10 AM ET

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
Motley Fool · Oct 24, 2026 12:31 PM ET

Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?
Motley Fool · Oct 22, 2026 6:15 PM ET

Should Upcoming Earnings Expectations Require Action From Cardinal Health Stock Investors?
Simply Wall St. · Oct 22, 2026 11:17 AM ET

Cardinal Health (CAH) Faces An Earnings Test On A Modestly Undervalued View
Simply Wall St. · Oct 22, 2026 10:14 AM ET

IBD Stock Of The Day Tests New Buy Point As Indicators Suggest More Upside
Investor's Business Daily · Oct 21, 2026 12:25 PM ET

Disposable Specimen Container Market Forecast Report 2026-2030 | Capitalize on Sterile Automation and $3.97B Demand with Leading Players Thermo Fisher, Cardinal Health, SARSTEDT and Greiner Bio-One
GlobeNewswire · Oct 21, 2026 4:05 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CAH's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.